Natrix Separations Now Part of Merck
New Acquisition to Advance Next Generation Bioprocessing

Biomanufacturers are moving toward Next Generation Processing because of its many benefits, including increased plant productivity, facility flexibility, cost efficiencies and reduced risk. Continuous processing is expected to triple in market size between 2020 and 2025.

The acquisition of Natrix Separations complements our efforts to drive Next Generation Bioprocessing, an area of increasing importance to our customers. Next Generation Bioprocessing is any technology, expendable, or system which significantly changes the existing mAb manufacturing template to deliver higher productivity, augmented manufacturing flexibility, increased speed, and reduced risk.

Natrix is known for its unique single use membrane chromatography technology platform capable of delivering high productivity and impurity removal in a single use format. Natrix® products are compact and single use, eliminating validation, cleaning, sanitization, and storage, while also enabling flexible downstream processing; an ideal fit with intensified processing.

More Information

Press Release, 28 August 2017